Multiparametric Evaluation in Differentiating Glioma Recurrence from Treatment-Induced Necrosis Using Simultaneous 18F-FDG-PET/MRI: A Single-Institution Retrospective Study.

about

Multiparametric Evaluation in Differentiating Glioma Recurrence from Treatment-Induced Necrosis Using Simultaneous 18F-FDG-PET/MRI: A Single-Institution Retrospective Study.

Item

http://www.wikidata.org/entity/Q48246048

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Multiparametric Evaluation in ...... stitution Retrospective Study.

@en

Multiparametric Evaluation in ...... stitution Retrospective Study.

@nl

type

Item

label

Multiparametric Evaluation in ...... stitution Retrospective Study.

@en

Multiparametric Evaluation in ...... stitution Retrospective Study.

@nl

prefLabel

Multiparametric Evaluation in ...... stitution Retrospective Study.

@en

Multiparametric Evaluation in ...... stitution Retrospective Study.

@nl

P1476

Multiparametric Evaluation in ...... stitution Retrospective Study.

@en

P2093

A Jena

http://www.w3.org/2001/XMLSchema#string

A Jha

http://www.w3.org/2001/XMLSchema#string

G K Jadhav

http://www.w3.org/2001/XMLSchema#string

N K Damesha

http://www.w3.org/2001/XMLSchema#string

P Negi

http://www.w3.org/2001/XMLSchema#string

S K Sogani

http://www.w3.org/2001/XMLSchema#string

S M Verma

http://www.w3.org/2001/XMLSchema#string

S Taneja

http://www.w3.org/2001/XMLSchema#string

P2860

Recurrent glioblastoma treated with bevacizumab: contrast-enhanced T1-weighted subtraction maps improve tumor delineation and aid prediction of survival in a multicenter clinical trial.

Comparison of magnetic resonance spectroscopy and positron emission tomography in detection of tumor recurrence in posttreatment of glioma: A diagnostic meta-analysis.

Multimodal imaging of gliomas in the context of evolving cellular and molecular therapies.

Pitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy - detecting illusive disease, defining response.

Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas.

Glioma recurrence versus radiation necrosis: accuracy of current imaging modalities.

Pseudoprogression and pseudoresponse: imaging challenges in the assessment of posttreatment glioma.

Multimodality assessment of brain tumors and tumor recurrence.

Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma.

Potential for differentiation of pseudoprogression from true tumor progression with dynamic susceptibility-weighted contrast-enhanced magnetic resonance imaging using ferumoxytol vs. gadoteridol: a pilot study.

P304

899-907

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3174/AJNR.A5124

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28341716

http://www.w3.org/2001/XMLSchema#string